Our company -
The Pathelen Healthcare AG






press release: click here

COMPANY

Find out more about us


Pathelen Health Care AG is a Swiss biotech company that has developed innovative forms of therapy for the treatment and cure of various diseases in more than 7 years of research and development. Pathelen Health Care AG specializes in the fight against bacteria and multi-resistant germs.

Pathelen® Hybrid is able to easily and effectively adsorb wound exudate, biofilm and pathogenic germs due to its physical mode of action. Pathelen® Hybrid completely dispenses with cytotoxic and pharmacological agents, as these hinder the formation of granulation tissue.

Pipeline with fully developed products:

  • Pathelen® Gel for the aftercare of chronic wounds
  • PHC suspension for the treatment of cystitis with multi-resistant germs
  • Pathelen® Gel for the treatment of gingivitis


The company has built a stable and diversified product pipeline with effective active ingredients. These demonstrate the potential for new treatment options in dermatology, surgery and urology.

Pathelen Healthcare AG

Our Team –
Pathelen Healthcare AG

TEAM

Dr. hc A. Tausch

Founder, President of the
Board of Directors

 

Bijan Sabet

CEO, Member of
the Board of Directors
 

Dr. Steven J. Kavros

Clinical Advisor
 
   

Shepard Bentley

Regulatory Advisor